ABBV vs AAPL
AbbVie Inc. vs Apple Inc.
ABBV
AbbVie Inc.
$232.03+3.27%
AAPL
Apple Inc.
$264.18-3.21%
Key Metrics Comparison
| ABBV | Metric | AAPL |
|---|---|---|
| $232.03 | Price | $264.18 |
| $410.09B | Market Cap | $3.88TBetter |
| 98.74 | P/E Ratio | 33.40Better |
| $2.35 | EPS | $7.91Better |
| +3.27%Better | Day Change | -3.21% |
| $244.81 | 52W High | $288.62 |
| $164.39 | 52W Low | $169.21 |
| 4,213,578 | Volume | 59,494,114Better |
| 6,401,624 | Avg Volume | 48,357,335Better |
About AbbVie Inc.
Healthcare | Drug Manufacturers - General
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for th...
About Apple Inc.
Technology | Consumer Electronics
Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising Ai...